Form 8-K - Current report:
SEC Accession No. 0001558370-22-017922
Filing Date
2022-11-15
Accepted
2022-11-15 08:02:18
Documents
12
Period of Report
2022-11-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20221115x8k.htm   iXBRL 8-K 33526
  Complete submission text file 0001558370-22-017922.txt   153099

Data Files

Seq Description Document Type Size
2 EX-101.SCH aytu-20221115.xsd EX-101.SCH 3133
3 EX-101.LAB aytu-20221115_lab.xml EX-101.LAB 15905
4 EX-101.PRE aytu-20221115_pre.xml EX-101.PRE 10062
6 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20221115x8k_htm.xml XML 4914
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 221389443
SIC: 2834 Pharmaceutical Preparations